1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N3063
    Pimaric acid Inhibitor 98.76%
    Pimaric acid 是一种树脂酸,具有抗癌作用,发现于海松 (A. cordata) 和各种松树中。Pimaric acid 在人卵巢癌细胞中通过内质网应激、caspase 依赖性凋亡、细胞周期阻滞和细胞迁移抑制发挥抗癌作用。Pimaric acid 降低 TNF-α 刺激的人主动脉平滑肌细胞 (HASMCs) 中基质金属蛋白酶-9 (MMP-9) 的 mRNA 表达、蛋白水平和启动子活性。
    Pimaric acid
  • HY-N2099
    Onjisaponin B

    远志皂苷B

    Inhibitor 99.10%
    Onjisaponin B 是一种从远志中发现的具有口服活性的天然产物。Onjisaponin B 能够抑制 NF-κB p65。Onjisaponin B 能够增强自噬 (autophagy),加速突变型 α-突触核蛋白和亨廷顿蛋白的降解。Onjisaponin B 能够减少 β-淀粉样蛋白 () 的生成。Onjisaponin B 能够减轻辐射诱导的细胞凋亡 (apoptosis)。Onjisaponin B 具有抗氧化和抗炎活性。Onjisaponin B 可用于神经系统疾病和放射损伤研究,其代谢物远志素 (TF) 能够穿透血脑屏障进入脑组织。
    Onjisaponin B
  • HY-N3181
    Nodosin Inhibitor 98.44%
    Nodosin 是一种可以从 Isodon serra 中分离得到的具有口服活性的二萜类化合物。Nodosin 可抑制肿瘤细胞增殖,诱导细胞周期阻滞和凋亡 (apoptosis)。Nodosin 也能抑制氧化应激、炎症反应和铁死亡 (ferroptosis)。 Nodosin 具有抗炎和抗肿瘤的活性。
    Nodosin
  • HY-N0168A
    (Rac)-Hesperetin 99.28%
    (Rac)-Hesperetin 是 Hesperetin 的外消旋体。Hesperetin 是一种天然黄烷酮,存在于柑橘类水果中,是一种强效且具有口服活性的广谱人类 UGT 活性抑制剂。Hesperetin 通过激活 p38 MAPK 诱导细胞凋亡。Hesperetin 具有多种生物活性,包括抗氧化、抗炎和抗癌。Hesperetin 可诱导细胞周期停滞于 G2/M 期。Hesperetin 可以降低 Bcl-2 并增强 BaxM。Hesperetin 通过抑制 NF-κB 受体诱导细胞凋亡 (apoptosis)。
    (Rac)-Hesperetin
  • HY-100977
    Dimethoxycurcumin Inhibitor 98.40%
    Dimethoxycurcumin 是 curcumin 的衍生物,具有抗炎和抗氧化活性。
    Dimethoxycurcumin
  • HY-126066
    (-)-Syringaresinol

    (-)-丁香树脂酚

    Inhibitor 99.95%
    (-)-Syringaresinol 是 Syringaresinol (HY-N8307) 的异构体,可在 Annona Montana 中发现,具有抗癌活性。Syringaresinol 是 NO 合酶磷酸化的激活剂,并诱导血管舒张。Syringaresinol 还抑制 NF-κB 通路,发挥抗炎活性。
    (-)-Syringaresinol
  • HY-W014223
    2,4′-Dihydroxybenzophenone

    二苯甲酮 -1

    Inhibitor 98.00%
    2,4′-Dihydroxybenzophenone (Ultraviolet absorber UV-0) 占据 MD2 的疏水口袋并阻止 TLR4 的二聚化。2,4′-Dihydroxybenzophenone 抑制 LPS 诱导的 mtROS 产生,并通过下调促炎介质、降低 MyD88 的表达、IRAK4 和 NF-κB 的磷酸化来抑制 LPS 诱导的炎症反应。2,4′-Dihydroxybenzophenone 也是一种紫外线吸收剂。
    2,4′-Dihydroxybenzophenone
  • HY-N0608
    Myrislignan Inhibitor 99.46%
    Myrislignan 是从Myristica fragrans Houtt 分离得到的一种木酚素,具有抗炎活性。Myrislignan 通过抑制NF-kB信号通路的激活,减轻LPS诱导的小鼠巨噬细胞炎症反应。
    Myrislignan
  • HY-N2101
    Benzoyloxypaeoniflorin

    苯甲酰氧化芍药苷

    Inhibitor 98.60%
    Benzoyloxypaeoniflorin 分离于 Paeonia suffruticosa 的根,是 tyrosinase 抑制剂,对蘑菇 tyrosinase 的 IC50为 0.453 mM。Benzoyloxypaeoniflorin 是 NF-κB 抑制剂,Benzoyloxypaeoniflorin 通过对血小板聚集和凝血的抑制作用,有助于改善血液循环。
    Benzoyloxypaeoniflorin
  • HY-15530
    CID-2858522 Inhibitor 99.78%
    CID-2858522 是一种高效的选择性抗原受体介导的 NF-κB 抑制剂,IC50 为 70 nM。
    CID-2858522
  • HY-N6812
    Karacoline

    多根乌头碱

    ≥99.0%
    Karacoline 是在植物 Aconitum kusnezoffii 中发现的二萜生物碱,能通过 NF-κB 信号通路减少椎间盘退变中细胞外基质的降解。
    Karacoline
  • HY-W015883R
    Fumaric acid (Standard)

    反丁烯二酸 (Standard)

    Inhibitor 99.93%
    Fumaric acid (Standard) 是 Fumaric acid 的分析标准品。本产品用于研究及分析应用。Fumaric acid 是一种不饱和二碳酸,是柠檬酸循环的中间产物,以 ATP 的形式提供细胞内能量。Fumaric acid 通过抑制 p38 MAPK 依赖的 NF-κB 信号通路发挥抗炎作用。Fumaric acid 可用于妊娠高血压的研究。
    Fumaric acid (Standard)
  • HY-B0185AS
    Lidocaine-d10 hydrochloride

    盐酸利多卡因 d10 (盐酸盐)

    Inhibitor 99.55%
    Lidocaine-d10 (hydrochloride) 是 Lidocaine hydrochloride 的氘代物。Lidocaine (Lignocaine) hydrochloride 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride 是一种酰胺衍生物,具有研究室性心律失常的潜力。
    Lidocaine-d<sub>10</sub> hydrochloride
  • HY-P990018
    Boserolimab Activator 99.00%
    Boserolimab (MK-5890) 是一种人源化激动剂单克隆抗体,可与 CD27 结合以提供增强 T 细胞介导反应的共刺激信号。
    Boserolimab
  • HY-N6826
    Asatone

    细辛酮

    Activator 99.94%
    Asatone 是从细辛中分离到的一种活性成分,具有抗炎活性,通过活化 NF-κB 及下调 p-MAPK (ERKJNK 和 p38) 通路起作用。
    Asatone
  • HY-N6599
    3-Feruloylquinic acid Inhibitor 98.98%
    3-Feruloylquinic acid (3-O-Feruloylquinic acid) 是奎宁酸结合酚酸的衍生物,具有抗氧化和抗炎活性。
    3-Feruloylquinic acid
  • HY-N1513
    Ganoderic acid H

    灵芝酸H

    Inhibitor 99.68%
    Ganoderic acid H 是一种从灵芝中提取的羊毛脂烷型三萜,能通过抑制转录因子AP-1 和 NF-kappaB 信号来抑制乳腺癌细胞细胞的生长和入侵。
    Ganoderic acid H
  • HY-N0176R
    Dihydroartemisinin (Standard)

    双氢青蒿素 (Standard)

    Inhibitor
    Dihydroartemisinin (Standard)是 Dihydroartemisinin 的分析标准品。本产品用于研究及分析应用。Dihydroartemisinin是一种有效的抗疟疾 (anti-malaria) 活性分子。
    Dihydroartemisinin (Standard)
  • HY-N0276
    Flaconitine

    乙酰乌头碱

    Inhibitor 99.77%
    Flaconitine 是一种生物碱。Flaconitine 是一种 NF-κB 抑制剂。
    Flaconitine
  • HY-N6046
    Kamebakaurin Inhibitor 98.36%
    Kamebakaurin 是一种可以从 Isodon excia (Maxin.) 分离得到的二萜类化合物,具有口服活性。Kamebakaurin 可以通过直接靶向 p50 的 DNA 结合活性抑制 NF-κB 激活。Kamebakaurin 能诱导肿瘤细胞凋亡 (apoptosis) 和细胞周期阻滞。Kamebakaurin 具有抗炎和抗肿瘤的活性。
    Kamebakaurin
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.